Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 1,243,336 | 933,013 | 701,887 | 540,099 | 380,833 |
| Cost of Goods | 150,343 | 139,989 | 97,049 | 63,382 | 56,586 |
| Gross Profit | 1,092,993 | 793,024 | 604,838 | 476,717 | 324,247 |
| Operating Expenses | 1,361,160 | 1,330,214 | 1,064,597 | 1,041,262 | 1,030,396 |
| Operating Income | -267,824 | -536,201 | -459,710 | -564,163 | -705,563 |
| Other Income | -252,274 | -153,762 | 40,762 | 11,098 | -8,317 |
| Pre-tax Income | -520,098 | -689,963 | -418,948 | -553,065 | -713,880 |
| Income Tax | 15,879 | 13,525 | -168 | 1,063 | 1,195 |
| Net Income Continuous | -535,977 | -703,488 | -418,780 | -554,128 | -715,075 |
| Net Income | $-535,977 | $-703,488 | $-418,780 | $-554,128 | $-715,075 |
| EPS Basic Total Ops | -5.80 | -8.03 | -5.15 | -7.11 | -9.71 |
| EPS Basic Continuous Ops | -5.80 | -8.03 | -5.15 | -7.11 | -9.71 |
| EPS Diluted Total Ops | -5.80 | -8.03 | -5.15 | -7.11 | -9.71 |
| EPS Diluted Continuous Ops | -5.80 | -8.03 | -5.15 | -7.11 | -9.71 |
| EPS Diluted Before Non-Recurring Items | -5.80 | -8.03 | -5.15 | -7.11 | -9.71 |
| EBITDA(a) | $-269,603 | $-504,988 | $-421,795 | $-537,252 | $-681,063 |